# Ellipse Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ellipse-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.ellipse-tech.com
- Total disclosed funding: $18M
- Latest round: Series C (Aug 2, 2011)
- Investors on record: 4

## About

Ellipse Technologies, Inc. is a technology firm that specializes in delivering innovative software solutions to optimize operational efficiency for medium to large enterprises across various sectors.Founded in 2005, Ellipse Technologies, Inc. is headquartered in Irvine, California, US. The company focuses on developing technology solutions that enhance business efficiency. In January 2016, the firm underwent a significant transition when NuVasive, Inc. acquired it for USD 380 mn upfront with potential additional payments in the following year. Ellipse Technologies has completed a total of 4 deals since its inception, showcasing a commitment to growth and strategic partnerships.Ellipse Technologies provides a comprehensive software platform that integrates data analytics, project management, and customer relationship management functionalities. Its solutions are tailored for medium to large enterprises aiming to overcome challenges related to data silos and inefficient workflows. The company has a diverse clientele across industries such as finance, healthcare, and retail, primarily within North America and Europe, benefiting from its user-friendly interface and robust support services.The revenue model of Ellipse Technologies is subscription-based, which allows for ongoing access to its software and support services. Clients typically engage in annual contracts with tiered pricing based on user numbers or service features. The core product, developed with customer feedback, caters to the diverse needs of different industries, contributing to a stable revenue stream through direct transactions with clients.Following its acquisition by NuVasive in January 2016, Ellipse Technologies is expected to leverage its new resources to enhance its product offerings and expand market reach. The company is in the process of designing new features aimed at enhancing operational efficiencies and plans to enter new geographic markets by 2023. The funding from the acquisition will be utilized to support these product developments and market expansions.

## Funding rounds

- Series C, Aug 2, 2011, $18M — HBM Partners, Wexford Capital, BioStar Capital, MedFocus Funds

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C
- Wexford Capital — Series C
- BioStar Capital (https://capitalatlas.ai/funds/biostar-capital) — Series C
- MedFocus Funds (https://capitalatlas.ai/funds/medfocus-funds) — Series C